Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Dec;98(12):e164-5.
doi: 10.3324/haematol.2013.099077.

Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia"

Affiliations
Comment

Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia"

Chiara Palmi et al. Haematologica. 2013 Dec.
No abstract available

Keywords: IKZF1 deletions; copy number abnormalities; pediatric Ph- BCP-ALL; prognosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Gene expression values for IKZF1probes 1565816_at (A) and 1565818_s_at (B) in patients with (DEL) and without (WT) IKZF1 deletions.
Figure 2.
Figure 2.
Gene expression values for IKZF1 by RQ-PCR in patients with (DEL) and without (WT) IKZF1 deletions. Boxes include 10–90 percentile, mean (internal line) and median (cross) are shown. Dots indicate outliers.

Comment on

References

    1. Palmi C, Valsecchi MG, Longinotti G, Silvestri D, Carrino V, Conter V, et al. What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? Haematologica. 2013;98(8): 1226–31 - PMC - PubMed
    1. Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T, et al. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Cancer Med. 2013;2(3): 412–9 - PMC - PubMed
    1. Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, et al. Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2013;98(4): 597–601 - PMC - PubMed
    1. Brady BL, Steinel NC, Bassing CH. Antigen receptor allelic exclusion: an update and reappraisal. J Immunol. 2010;185(7): 3801–8 - PMC - PubMed
    1. Mullighan CG, Su X, Zhang J, Radtke I, Philips LAA, Miller CB, et al. Deletion of IKZF1 and Prognois in Aute Lymphoblastic Leukemia. N Engl J Med. 2009;360(5): 470–80 - PMC - PubMed

MeSH terms

Substances